These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2014025)

  • 21. Gastric cancer cell DNA content correlates with early and late results after gastrectomy.
    Carlini M; Garofalo A; Rinaldi G; D'Agnano I; D'Angelo C; Zupi G; Vecchione A; Santoro E
    Int Surg; 1994; 79(2):114-9. PubMed ID: 7928145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is DNA aneuploidy a prognostic factor in gastric cancer?
    Omejc M; Repse S; Bracko M
    Acta Chir Hung; 1997; 36(1-4):266-9. PubMed ID: 9408370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term survival in terms of DNA-RNA contents in breast cancer].
    Hara S; Kondo M; Tagawa Y; Itoyanagi N; Kishimoto K; Matuo S; Akamine S; Takahashi T; Oka T; Ayabe H
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():422-5. PubMed ID: 9589046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
    Yokogi H
    Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma.
    Iwao Y; Kim YI; Kaketani K; Nakashima K; Okada K; Kobayashi M
    Hepatogastroenterology; 1993 Oct; 40(5):491-5. PubMed ID: 8270242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of mitotic metaphase rate in oesophageal cancer.
    Yasunaga M; Tabira Y; Imaoka S; Kitamura N
    Eur J Surg; 2000 Aug; 166(8):616-21. PubMed ID: 11003429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
    Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
    Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma].
    Yamaoka N; Uchiyama Y; Kimino K; Akamine S; Matsuo S; Tsuji K
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1608-16. PubMed ID: 2175839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
    Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
    Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Flow cytometric analysis of cellular DNA content of lung cancer with reference to survival].
    Shiota T; Konishi T; Kosaba S; Mitsuoka A; Matsubara Y; Hatakenaka R; Funatsu T; Ikeda S; Matsumoto H; Ishigami F
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Dec; 38(12):2364-9. PubMed ID: 2290045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic significance of flow cytometric DNA analysis in colorectal cancer].
    Ando Y
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1700-9. PubMed ID: 2277618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
    Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA ploidy patterns in gallbladder adenocarcinoma.
    Yamamoto M; Oda N; Tahara E
    Jpn J Clin Oncol; 1990 Mar; 20(1):83-6. PubMed ID: 2319702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Flow cytometric analysis of the DNA content in resected thymomas].
    Kushibe K; Iioka S; Nezu K; Sawahata A; Tojo H; Kitamura S
    Kyobu Geka; 1993 Jan; 46(1):79-83. PubMed ID: 8418365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nuclear DNA pattern and various prognostic factors of the gallbladder cancer].
    Goto H; Ouchi K; Owada Y; Matsuno S
    Nihon Geka Gakkai Zasshi; 1988 Nov; 89(11):1843-9. PubMed ID: 3205250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNA cytometry using paraffin embedded tumor tissues. Comparison of flow cytometry (FCM) and image cytometry (ICM)].
    Baretton G; Blasenbreu S; Li X; DePascale T; Löhrs U
    Zentralbl Pathol; 1994 Feb; 139(6):419-25. PubMed ID: 7512820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.